Heterocyclic gaba alpha subtype selective receptor modulators

The present invention provides a compound of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Y, Ar, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds.

Saved in:
Bibliographic Details
Main Authors COUNDE O'YANG, XIAO-FA LIN, JASON MANKA, MICHAEL SOTH, DENNIS MITSUGU YASUDA, DAVID GARRETT LOUGHHEAD
Format Patent
LanguageEnglish
Published 18.10.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides a compound of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Y, Ar, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds.
AbstractList The present invention provides a compound of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Y, Ar, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds.
Author JASON MANKA
XIAO-FA LIN
COUNDE O'YANG
DAVID GARRETT LOUGHHEAD
MICHAEL SOTH
DENNIS MITSUGU YASUDA
Author_xml – fullname: COUNDE O'YANG
– fullname: XIAO-FA LIN
– fullname: JASON MANKA
– fullname: MICHAEL SOTH
– fullname: DENNIS MITSUGU YASUDA
– fullname: DAVID GARRETT LOUGHHEAD
BookMark eNrjYmDJy89L5WSw9UgtSS3KT65MzslMVkhPTEpUSMwpyEhUKC5NKqksSFUoTs1JTS7JLEtVKEpNTi0oyS9SyM1PKc1JBLKKeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvGOokYGBuZGxqaWliaOhMXGqADjfM3E
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2007235994A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2007235994A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:02:08 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2007235994A13
Notes Application Number: AU20070235994
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071018&DB=EPODOC&CC=AU&NR=2007235994A1
ParticipantIDs epo_espacenet_AU2007235994A1
PublicationCentury 2000
PublicationDate 20071018
PublicationDateYYYYMMDD 2007-10-18
PublicationDate_xml – month: 10
  year: 2007
  text: 20071018
  day: 18
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies F. HOFFMANN-LA ROCHE AG
RelatedCompanies_xml – name: F. HOFFMANN-LA ROCHE AG
Score 2.6908126
Snippet The present invention provides a compound of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Y, Ar, R1 and R2 are...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Heterocyclic gaba alpha subtype selective receptor modulators
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071018&DB=EPODOC&locale=&CC=AU&NR=2007235994A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt-KWtun6UGRrO4awD2STvY0mTUTQdqwd4n_vJWy6p72EkINwCdxd7nL3O4DHTkBTJn3fFjxLbTfDIVBc2anyUuZkbSqVDugPR2wwc1_m3rwGn9taGIMT-m3AEVGiBMp7ZfT18j-IFZvcyvKJf-BS8dyfhrG19Y59DUBlxb0wmYzjcWRFEXqS1ujV0KjjBYHbRV_pQD-kNdJ-8tbTdSnLXaPSP4XDCe6XV2dQk3kDjqNt77UGHA03X9443UhfeQ7hQOeuFOJHIJPkPeUpMaWypFxzHUolpWlqg_qLoB6TS3SnyVeR6QZdxaq8gId-Mo0GNvKx-Dv2ojvbZdq5hHpe5PIKCGWeaIlWRzFHuQHjXPgelS0lqJJtRoNraO7b6WY_-RZOTPxSZ210mlCvVmt5h4a34vfmvn4BjJyIew
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWlb8UtbdP1YcjWblTdF7LJ3kaTJiJoO9YO8b_3Ejbd015CyMFxCdwdv8t9ANw3fRJT4XkWZ0lsOQkuvmTSiqUbUztpECFVQH8wpNHUeZ65sxJ8bmphdJ_Qb90cETWKo74X2l4v_oNYoc6tzB_YBx5lj71JKzQ36NhTDajMsNPqjkfhKDCDAJGkOXzVNGK7vu-0ESvteQgKVaf97ltH1aUstp1K7wj2x8gvLY6hJNIqVILN7LUqHAzWX964XWtffgKtSOWuZPyHo5DGe8xiQ5fKGvmKqVCqkeuhNmi_DLRjYoFw2vjKEjWgK1vmp3DX606CyEI55n_Xnren20LbZ1BOs1Scg0Goy-u83pTUlo5PGeOeS0RdciJFgxL_Amq7OF3uJt9CJZoM-vP-0_DlCg51LFNlcDRrUC6WK3GNTrhgN_rtfgEUxItm
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Heterocyclic+gaba+alpha+subtype+selective+receptor+modulators&rft.inventor=COUNDE+O%27YANG&rft.inventor=XIAO-FA+LIN&rft.inventor=JASON+MANKA&rft.inventor=MICHAEL+SOTH&rft.inventor=DENNIS+MITSUGU+YASUDA&rft.inventor=DAVID+GARRETT+LOUGHHEAD&rft.date=2007-10-18&rft.externalDBID=A1&rft.externalDocID=AU2007235994A1